A team led by Benjamin Izar and Elham Azizi have invented a new RNA sequencing method that achieves high-quality results from small volumes of frozen tumor specimens. They demonstrated the success of their technique in two clinical studies that profiled dozens of tumor samples, both those archived and those freshly collected, to understand how they respond to anti-tumor therapy. The paper was recently published in Nature Genetics.
Read more in Columbia Engineering news.
